⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

TEM

Tempus AI, Inc.

Healthcare · Health Information Services

61.28USD

-3.0100 (-4.68%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$-0.07▲$-0.0962
Next quarter$-0▲$-0.0263
Current year$-0.26▲$-0.3891
Next year$-0.02▲$-0.1181

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$-0.15$-0.04+0.11 (+73.6%)
2026-03-31$-0.2$-0.13+0.07 (+35.3%)
2025-12-31$-0.05$-0.04+0.01 (+22.1%)
2025-09-30$-0.18$-0.11+0.07 (+37.3%)

Wall Street coverage

83 ratings from 21 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Rothschild & CoInitiatedNeutral$67Sep 8, 2026
Roth CapitalInitiatedNeutral$67Sep 8, 2026
Cantor FitzgeraldInitiatedOverweight$80Sep 2, 2026
Piper SandlerUpgraded from NeutralOverweight$56 $76Sep 1, 2026
Freedom Capital MarketsMaintainedHold$51 $73Aug 31, 2026
BTIGMaintainedBuy$70 $80Aug 20, 2026
Piper SandlerMaintainedNeutral$58 $56Aug 4, 2026
BTIGMaintainedBuy$80 $70Aug 3, 2026
HC Wainwright & Co.MaintainedBuy$64 $56Aug 3, 2026
StifelMaintainedHold$60 $50Aug 3, 2026
NeedhamReiteratedBuy$75Jul 31, 2026
NeedhamReiteratedBuy$75Jul 20, 2026
GuggenheimMaintainedBuy$60 $65Jul 16, 2026
Freedom Capital MarketsInitiatedHold$59Jul 1, 2026
NeedhamReiteratedBuy$75Jun 1, 2026
BTIGReiteratedBuy$80Jun 1, 2026
HC Wainwright & Co.MaintainedBuy$95 $64May 11, 2026
BTIGMaintainedBuy$90 $80May 8, 2026
TD CowenMaintainedBuy$65 $68May 6, 2026
JefferiesInitiatedUnderperform$35Apr 13, 2026
GuggenheimMaintainedBuy$95 $60Mar 30, 2026
NeedhamReiteratedBuy$75Mar 11, 2026
HC Wainwright & Co.MaintainedBuy$89 $95Mar 9, 2026
Morgan StanleyMaintainedOverweight$85 $70Mar 3, 2026
JP MorganMaintainedNeutral$80 $60Feb 25, 2026

Insider transactions

166 filings from 19 insiders · 16 buy / 34 sell over 6m

Officers and directors of TEM, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Fukushima RyanOfficer, CEO, DataSellindirect1.0k$64.63$65kSep 1, 2026
Fukushima RyanOfficer, CEO, DataSellindirect5.9k$63.80$376kSep 1, 2026
Fukushima RyanOfficer, CEO, DataSellindirect10.9k$62.64$683kSep 1, 2026
Fukushima RyanOfficer, CEO, DataSellindirect13.0k$62.12$810kSep 1, 2026
Doudna Jennifer ADirectorSell676$65.55$44kSep 1, 2026
Epstein David RDirectorSell250$65.55$16kSep 1, 2026
West NadjaDirectorSell3.0k$69.00$207kAug 28, 2026
LEFKOFSKY ERIC PAULChairman of the BoardSellindirect238.2k$64.03$16.29MAug 25, 2026
LEFKOFSKY ERIC PAULChief Executive OfficerSellindirect11.8k$69.83$828kAug 25, 2026
SCHOENHERR THOMAS EDWARDOfficerSell2.7k$70.00$189kAug 21, 2026
FUKUSHIMA RYANOfficerSellindirect14.3k$70.00$1.00MAug 21, 2026
SCHOENHERR THOMAS EDWARDOfficerSell17.3k$49.61$930kAug 19, 2026
ROGERS JAMES WILLIAMChief Financial OfficerSell48.8k$49.61$2.70MAug 19, 2026
POLOVIN ANDREWOfficerSell30.1k$49.61$1.54MAug 19, 2026
LEFKOFSKY ERIC PAULChief Executive OfficerSell132.6k$49.61$6.58MAug 18, 2026
BARTOLUCCI RYAN MOfficerSell6.2k$49.61$306kAug 18, 2026
FUKUSHIMA RYANOfficerSell41.1k$49.61$2.04MAug 18, 2026
WEST NADJA Y.DirectorSell3.0k$53.90$162kAug 14, 2026
FUKUSHIMA RYANOfficerGiftindirect62.2k——Aug 12, 2026
FUKUSHIMA RYANOfficerSellindirect20.0k$50.04$1.00MAug 7, 2026

Analyst Notes

Sign in to write

No analyst notes on TEM yet.

Analyst Ratings

15 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current28610Buy2.35
1 mo ago17710Hold2.50
2 mo ago17710Hold2.50
3 mo ago28710Buy2.39
Price target$66.73$35.00 – $100.00
+8.9% to target